Intuitive Surgical, Inc. Dividend History (ISRG)
Intuitive Surgical, Inc. does not pay dividends currently 😔
They might in the future, check back soon!
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc., founded in 1995, is a pioneering medical technology company that specializes in robotic-assisted surgery. The company is best known for its da Vinci Surgical System, a sophisticated platform that enhances a surgeon's capabilities through advanced robotic and imaging technologies. The da Vinci system is designed to facilitate complex surgeries using a minimally invasive approach, which can lead to reduced recovery times and lower risks for patients. Intuitive Surgical is headquartered in Sunnyvale, California, and has expanded its reach globally, with a significant presence in hospitals and surgical centers around the world. As of the latest updates, Gary Guthart serves as the CEO, having held this position since 2010. The company has consistently demonstrated strong financial performance, driven by the growing adoption of robotic-assisted surgeries. In 2022, Intuitive Surgical reported revenues exceeding $6 billion, highlighting its leading role in the evolving landscape of healthcare technology. The company's commitment to innovation, education, and support continues to empower surgeons and improve patient outcomes worldwide.
Alphabet Inc.
DexCom, Inc.
Edwards Lifesciences Corporation
Elevance Health Inc.
Henry Schein, Inc.
IDEXX Laboratories, Inc.
Integer Holdings Corporation
Johnson & Johnson
Medtronic plc
Stryker CorporationThe medical robots market is projected to reach $34.32 billion by 2031, growing at a CAGR of 17.4% during the forecast period. The rising demand for minimally invasive surgeries, particularly among the aging population, is driving the market growth. Surgical robots are the largest segment, offering advantages like reduced scarring, faster recovery, and enhanced precision for surgeons.
GlobeNewswire Inc. · Published on Fri Nov 29 2024
The article discusses two healthcare companies, DexCom and Intuitive Surgical, that are well-positioned to deliver strong returns in the next decade. DexCom is a leader in continuous glucose monitoring systems, while Intuitive Surgical dominates the robotic-assisted surgery market with its da Vinci system.
The Motley Fool · Published on Thu Nov 28 2024
The article discusses three stocks - Netflix, Royal Caribbean Cruises, and Intuitive Surgical - that have recently surged in value but are still considered great long-term investments due to their strong growth potential and competitive advantages.
The Motley Fool · Published on Sat Nov 09 2024